NEW YORK (GenomeWeb) – The Massachusetts Life Sciences Center today said that Roche has joined the Center's Corporate Consortium Partners to support early stage life science firms in the state.

As a member, Roche will provide funding to support MLSC's investments in such businesses, and in return, Roche will have access to new technologies that may potentially lead to new healthcare solutions, MLSC said. According to an MLSC spokesperson, Roche will provide $250,000 to the consortium partner program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.